Loading chat...
ID H0003
Bill
Status
2/16/2017
Primary Sponsor
Health and Welfare Committee
Click for details
AI Summary
-
Amends Idaho Code Section 54-1704 to include prescribing tuberculin purified protein derivative (tuberculin skin test) products within the legal practice of pharmacy.
-
Pharmacists may prescribe and administer tuberculin purified protein derivative products for tuberculosis screening if acting in good faith and exercising reasonable care.
-
Pharmacists must complete a course on proper test administration and interpretation from the CDC or a comparable accredited provider before prescribing and administering the products.
-
Pharmacists must follow CDC recommendations for Mantoux tuberculin skin testing administration and interpretation, maintain documentation of results in pharmacy records, and provide results to patients upon request.
-
Pharmacists must refer patients with positive test readings to their primary care provider or local clinic for further diagnostics and must report positive results to the local health district or Idaho Department of Health and Welfare in accordance with reportable disease rules.
Legislative Description
Amends and adds to existing law to provide that prescribing tuberculin purified protein derivative products is within the practice of pharmacy; and to provide that a pharmacist may prescribe and administer a tuberculin purified protein derivative product under certain circumstances.
PHARMACISTS
Last Action
Reported Signed by Governor on February 16, 2017 Session Law Chapter 23 Effective: 07/01/2017
2/16/2017